A million cancer Patients' genetic data could unlock better treatments
NCT ID NCT02609269
First seen Aug 18, 2026 · Last updated Aug 18, 2026
Summary
This study aims to collect and analyze genetic and clinical information from up to one million people with prostate, bladder, or kidney cancer. The goal is to better understand tumor biology and how this information can be used to improve treatment decisions and outcomes. Participants will have their Decipher test results and clinical data shared for research purposes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to more personalized cancer treatment strategies and improved outcomes by linking genetic information with clinical data.
- What could go wrong
- This is an observational data-sharing study, not a treatment trial, so it may not directly change patient care. Its impact depends on the quality and completeness of the data collected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could removing extra lymph nodes during prostate surgery stop cancer from coming back?
- Can 3D imaging make prostate radiation more precise and worth the cost?
- Could a workout plan shield the heart during prostate cancer therapy?
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- Can a Bag-Like device pull bladder tumors out whole?